SM
GNCA

Sabby Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Sabby Management’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,032
Closed -$236K – 169
2020
Q3 		$236K Sell
1,032
-1,094
-51% -$2.87K 0.04% 96
2020
Q2 		$489K Buy
2,126
+925
+77% +$2.13K 0.1% 57
2020
Q1 		$207K Buy
+1,201
New +$2.43K 0.09% 54
2019
Q4 		– Sell
-1,481
Closed -$429K – 103
2019
Q3 		$429K Buy
+1,481
New +$5.06K 0.23% 45

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management's GNCA Position: Q4 2020 in Review

Sabby Management sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2020, closing a stake of 312,666 shares — an estimated $716K sold.

Sabby Management first reported a position in GNCA in Q1 2015 and held it in 10 quarters. The position peaked at $5M in Q3 2015. 39 funds tracked by Wall St. Rank hold GNCA as of Q4 2020.

  • Sabby Management reported no remaining Genocea Biosciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • Sabby Management sold 312,666 Genocea Biosciences, Inc. shares in Q4 2020, an estimated $716K.
  • Sabby Management first reported a position in Genocea Biosciences, Inc. in Q1 2015 and held it in 10 quarters.
  • Sabby Management's Genocea Biosciences, Inc. position peaked at $5M in Q3 2015.
  • 39 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2020.

Based on Sabby Management's 13F filing for Q4 2020, filed 16 Feb 2021.